THRD Third Harmonic Bio Inc.: Forvard narx/daromad multiplikatori
Third Harmonic Bio zararli emissiyalarni kamaytirish uchun immun dori vositalarini ishlab chiqishga ESG tamoyillarini integratsiya qilmoqda. Bozor kutganlarini aks ettiruvchi forward sotuvlar nisbati (price-to-sales ratio) ko'rsatkichi yangi qiymatiga yetdi. Dori vositalari uchun kuchli intellektual mulk himoyasi yuqori o'sish potentsialini ta'minlaydi, sezilarli naqd pul rezervi esa kompaniyaga tashqi sherikliklarga tayanmasdan mustaqil tadqiqotlar va ishlanmalarni olib borish imkonini beradi.
Third Harmonic Bio Inc (THRD) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- biznesning balans baholash tafsilotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Third Harmonic Bio|THRD - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Third Harmonic Bio|THRD - Kompaniyaning jamlangan qarzi|Qarzning balans qiymatiga nisbati Third Harmonic Bio Inc|THRD - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzlari Third Harmonic Bio|Tezkor likvidlik koeffitsiyenti thirdharmonicbio.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
THRD - Sof foyda|Kutilayotgan foyda Third Harmonic Bio|THRD - Kompaniya qiymatining sof foydaga nisbati|Kelajakdagi narxning foydaga nisbati Third Harmonic Bio, Inc|THRD - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Third Harmonic Bio Inc|THRD - Foizlar, soliqlar va eskirishdan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Third Harmonic Bio|THRD - So'nggi 12 oy davomida bir aksiya uchun foyda|Choraklik EPS foyda o'sishi thirdharmonicbio.com|THRD - Bu yil bir aksiya uchun sof foydaning kutilayotgan o'sishi|Keyingi yil uchun foyda o'sishi prognozi Third Harmonic Bio
- kompaniyaning sotuvlari va tushumi statistikasi:
Kompaniyaning fundamental baholanishi:Third Harmonic Bio, Inc. (THRD)
Third Harmonic Bio immunoterapiyasining qarzdorlikning yo'qligi va patent himoyasi prognoz qilingan P/S tendentsiyasi orqali kapitalizatsiyani baholash uchun barqaror asos yaratadi. Ushbu ko'rsatkich emitentning bozor qiymatini prognoz qilingan daromadlar bilan solishtiradi, bu esa investorlarga real aktivlarning o'sishini spekulyativ tebranishlardan ajratish va biznesning kelajakdagi pul oqimlari nisbatan haddan tashqari yuqori baholanganlik darajasini aniq belgilash imkonini beradi.
Muhim raqobatchilar
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ABVX: Forvard narx/daromad multiplikatori|ADMA Corp - Narxning kutilayotgan daromadga nisbati|PTGX: Forvard P/S multiplikatori|immunovant.com - Sotuvga nisbatan forvard narx|KNSA (Kiniksa) - Forvard P/S multiplikatori|Grifols SA (GRFS) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Adaptive Biotechnologies Corp (ADPT)|CLDX (Celldex Corp) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori AUPH (Aurinia Pharmaceuticals)|BCRX: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|VERA: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx DNTH (Dianthus Therapeutics Inc)|PHVS: Forvard P/S multiplikatori|AbCellera Corp - Sotuvga nisbatan forvard narx|TRML (Tourmaline Bio, Inc.) - Forvard P/S multiplikatori|Forvard P/S multiplikatori precigen.com|Narxning prognoz qilingan daromadga nisbati Pharming Group (PHAR)|NKTR (Nektar Therapeutics Inc) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Upstream Bio Corp UPB|ZBIO - Forvard narx/daromad multiplikatori|IMNM - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati gossamerbio.com|KalVista Pharmaceuticals, Inc. (KALV) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati SEPN|PVLA (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|Savara Pharma (SVRA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori RIGL|Forvard narx/daromad multiplikatori anaptysbio.com ANAB|Astria Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx ENGN|RAPT Therapeutics, Inc. - Forvard P/S multiplikatori|JBIO: Narxning prognoz qilingan daromadga nisbati|ACRS: Forvard P/S multiplikatori|KYTX - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Tiziana Life Sciences Ltd|Bozor kapitallashuvining kelajakdagi daromadga nisbati Cabaletta Bio Inc. CABA|Forvard narx/daromad multiplikatori VTYX (Ventyx Bio)|Narxning kutilayotgan daromadga nisbati THTX|Forvard P/S multiplikatori AVTX (Avalo Therapeutics, Inc)|Sotuvga nisbatan forvard narx ELDN|AGEN - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx CLYM (Climb Bio Inc.)|ZURA: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ATYR|Narxning prognoz qilingan daromadga nisbati Adagene Inc|Ikena Oncology, Inc. - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori STTK|EQ (equilliumbio.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CNTB (Connect Biopharma Holdings Limited)|Forvard P/S multiplikatori Immunic Therapeutics IMUX|ATRA - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx IFRX (InflaRx N.V.)|X4 Pharmaceuticals, Inc. (XFOR) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Adicet Bio, Inc.|CELU (Celularity Inc) - Forvard P/S multiplikatori|Forvard P/S multiplikatori INmune Bio Corporation|Forvard narx/daromad multiplikatori BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SABS (SAB Biotherapeutics, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Akari Therapeutics PLC (AKTX)|ENLV - Narxning prognoz qilingan daromadga nisbati|Q32 Bio Inc. (QTTB) - Forvard narx/daromad multiplikatori|GeoVax Labs, Inc. (GOVX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori edesabiotech.com|Forvard narx/daromad multiplikatori IBIO|Forvard P/S multiplikatori Carisma Tx|Narxning prognoz qilingan daromadga nisbati XTL Biopharmaceuticals, Ltd. (XTLB)|boltbio.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori HCWB (HCW Biologics)|Aptevo Therapeutics, Inc. (APVO) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|AIM: Forvard narx/daromad multiplikatori|Aditxt - Narxning kutilayotgan daromadga nisbati|GRI: Forvard P/S multiplikatori|XORTX Corp - Sotuvga nisbatan forvard narx|HIND (Vyome Holdings Inc) - Forvard P/S multiplikatori|revbiosciences.com (REVB) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Indaptus Therapeutics, Inc. (INDP)|SCNI (Scinai Immunotherapeutics Ltd) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CALI (CalciMedica)|AFMD: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ALLK: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx HOOK (HOOKIPA Pharma Inc.)|IGMS: Forvard P/S multiplikatori|iTeos Therapeutics Inc - Sotuvga nisbatan forvard narx|OCEA (Ocean Bio) - Forvard P/S multiplikatori|Forvard P/S multiplikatori TC BioPharm Ltd
